Upgrade to SI Premium - Free Trial

BioScrip (BIOS) PT Raised to $3.50 at Craig-Hallum

March 8, 2018 1:44 PM

Craig-Hallum raised its price target on BioScrip (NASDAQ: BIOS) to $3.50 while maintaining a Buy rating.

Analyst Kevin Ellich likes the effort from management to clean up it's operations. The analyst believes Q4 results were good and thinks FY 2018 guidance is conservative.

Categories

Analyst Comments Analyst PT Change